```html

Amaurosis Fugax – A Complete Guide

What is Amaurosis fugax?

Amaurosis fugax (Latin for “fleeting blindness”) is a brief, sudden loss of vision in one eye that lasts from a few seconds to several minutes and then resolves completely. The episode is typically described as a “curtain” or “shade” descending over the visual field, often resembling a blackout that is painless and does not affect eye movement. Although the event is transient, it is a warning sign of underlying vascular disease and should be evaluated promptly.

Because the problem originates from the blood supply to the retina rather than the eye’s optical structures, the term “amaurosis” (loss of vision) is combined with “fugax” (temporary). In many cases the episode is the ocular equivalent of a transient ischemic attack (TIA) of the brain.

Common Causes

The most frequent mechanisms involve embolic or hemodynamic interruption of blood flow to the retina. Below are the eight‑to‑ten most common conditions that can precipitate amaurosis fugax.

• Carotid artery atherosclerosis – Plaque in the internal carotid artery can release cholesterol or platelet‑rich emboli that travel to the ophthalmic artery.
• Cardio‑embolic sources – Atrial fibrillation, recent myocardial infarction, valvular disease, or intracardiac thrombus can send clots to the retinal circulation.
• Giant cell arteritis (temporal arteritis) – Inflammation of the large arteries of the head can cause transient occlusion of the ophthalmic artery.
• Hypercoagulable states – Conditions such as antiphospholipid syndrome, factor V Leiden, or malignancy‑related coagulopathy increase clot formation.
• Emboli from aortic arch atheroma – Calcified plaques in the aortic arch can shed debris that reaches the eye.
• Retinal artery vasospasm – Migraine‑related or drug‑induced vasospasm (e.g., cocaine, ergotamine) can temporarily narrow the retinal artery.
• Ocular or orbital tumors – Rarely, a mass can compress the central retinal artery.
• Inflammatory ocular diseases – Severe uveitis or optic neuritis can produce transient visual loss, though usually with pain.
• Systemic hypotension – Severe dehydration, blood loss, or heart failure may reduce ocular perfusion.
• Eye‑related trauma or acute intra‑ocular pressure spikes – Though uncommon, sudden pressure changes can mimic transient blindness.

Associated Symptoms

Amaurosis fugax frequently occurs with other neurologic or systemic signs, helping clinicians pinpoint the underlying cause.

• Transient weakness, numbness, or speech difficulty (suggesting a concurrent cerebral TIA).
• Headache, especially in the temporal region, or scalp tenderness (classic for giant cell arteritis).
• Palpitations, irregular heartbeat, or known atrial fibrillation.
• Neck pain or bruit over the carotid artery.
• Unexplained weight loss, night sweats, or fever (possible systemic vasculitis or malignancy).
• Visual disturbances in the other eye (less common, but may indicate bilateral embolic disease).
• Symptoms of hypercoagulability – such as recurrent deep‑vein thrombosis or pulmonary embolism.

When to See a Doctor

Because amaurosis fugax can be a harbinger of stroke, urgent medical attention is recommended. Seek care promptly if you experience:

• Any sudden loss of vision, even if it resolves within seconds.
• Accompanying neurological symptoms (slurred speech, weakness, numbness).
• Headache or scalp tenderness, especially in people over 50.
• Recent chest pain, shortness of breath, or palpitations suggesting a cardiac source.
• Recurrent episodes of transient vision loss.
• History of carotid artery disease, atrial fibrillation, or prior TIA/stroke.

If you are unsure, err on the side of caution and call emergency services (999/112 in the UK, 911 in the US) – early evaluation can prevent a full‑blown stroke.

Diagnosis

A systematic work‑up combines history, physical examination, and targeted investigations.

Clinical Assessment

• History – Timing, duration, precipitating factors, and associated symptoms; cardiovascular risk profile (smoking, hypertension, diabetes, dyslipidemia).
• Physical exam – Blood pressure, cardiac rhythm, carotid bruit, ocular exam (visual acuity, pupil reflexes), and a brief neurologic screen.

Imaging & Laboratory Studies

• Carotid duplex ultrasonography – First‑line, non‑invasive test to detect stenosis or plaque in the carotid arteries.
• CT angiography (CTA) or MR angiography (MRA) – Detailed visualization of cervical and intracranial vessels when duplex results are equivocal.
• Brain MRI with diffusion‑weighted imaging – Detects acute ischemic lesions that may accompany a TIA.
• Echocardiography (transthoracic or transesophageal) – Evaluates cardiac sources of emboli.
• Electrocardiogram (ECG) & Holter monitor – Identifies atrial fibrillation or other arrhythmias.
• Blood tests – CBC, ESR/CRP (to rule out giant cell arteritis), fasting lipid panel, fasting glucose/HbA1c, coagulation profile, antiphospholipid antibodies if suspicion of hypercoagulable state.
• Fundoscopic examination – May reveal retinal artery emboli (“Hollenhorst plaques”) or signs of ocular ischemia.

Diagnostic Criteria

Diagnosis is clinical, supported by evidence of an embolic source or vascular disease. The American Heart Association classifies amaurosis fugax as a retinal TIA, and management follows TIA guidelines.

Treatment Options

Treatment aims to prevent a future stroke and address the underlying cause.

Medical Therapy

• Antiplatelet agents – Aspirin 81‑325 mg daily or clopidogrel 75 mg daily; dual therapy is reserved for high‑risk cases.
• Anticoagulation – Indicated if atrial fibrillation, left‑ventricular thrombus, or a hypercoagulable disorder is present (e.g., warfarin with INR 2‑3, or direct oral anticoagulants).
• Statin therapy – High‑intensity statins (atorvastatin 40‑80 mg or rosuvastatin 20‑40 mg) reduce plaque progression and lower stroke risk.
• Blood pressure control – Target <130/80 mmHg per ACC/AHA guidelines.
• Glycemic control – For diabetics, maintain HbA1c <7 % (individualized).
• High‑dose corticosteroids – If giant cell arteritis is diagnosed (e.g., prednisone 40‑60 mg daily), start immediately to prevent permanent visual loss.

Procedural Interventions

• Carotid endarterectomy (CEA) – Recommended for symptomatic carotid stenosis ≥70 % in patients with low surgical risk.
• Carotid artery stenting (CAS) – Alternative for patients unsuitable for surgery (e.g., severe neck anatomy, high surgical risk).
• Cardiac interventions – Catheter ablation for atrial fibrillation, valve replacement, or closure of a patent foramen ovale if implicated.

Home & Lifestyle Measures

• Quit smoking – nicotine accelerates atherosclerosis.
• Adopt a Mediterranean‑style diet rich in fruits, vegetables, whole grains, nuts, and fish.
• Engage in regular aerobic exercise (≥150 min/week moderate intensity).
• Maintain a healthy weight (BMI 18.5‑24.9 kg/m²).
• Limit alcohol intake to ≤2 drinks per day for men, ≤1 for women.
• Manage stress with relaxation techniques, yoga, or counseling.

Prevention Tips

Because many causes are linked to atherosclerotic disease, primary prevention mirrors cardiovascular health strategies.

1. Control risk factors – Annual blood pressure, lipid, and glucose screening.
2. Take prescribed meds consistently – Never discontinue antiplatelet or anticoagulant therapy without physician guidance.
3. Regular ophthalmic and vascular check‑ups – Particularly if you have known carotid plaque or cardiac arrhythmias.
4. Vaccinations – Influenza and COVID‑19 vaccines reduce systemic inflammation that can destabilize plaques.
5. Promptly treat infections – Dental or sinus infections can increase embolic risk in patients with existing plaques.
6. Monitor for medication side‑effects – For example, oral contraceptives or hormone replacement therapy increase clot risk; discuss alternatives with your doctor.

Emergency Warning Signs

Key Take‑aways

• Amaurosis fugax is a brief, painless loss of vision that signals possible embolic disease.
• Carotid atherosclerosis and cardiac sources are the most common culprits.
• Prompt medical evaluation (including carotid imaging and cardiac work‑up) is essential.
• Treatment focuses on antiplatelet/anticoagulant therapy, risk‑factor modification, and, when indicated, carotid or cardiac procedures.
• Never ignore a visual “blackout”—it may be the first warning sign of a future stroke.

For further reading, consult reputable sources such as the Mayo Clinic, American Heart Association, CDC, and peer‑reviewed journals like Neurology and Ophthalmology.

```